Minimal change disease in a patient receiving IFN-α therapy for chronic hepatitis C virus infection

Journal of Interferon and Cytokine Research

Volumn 23, Issue 1, 2003, Pages 51-54

  Dizer, Ufuk ^a   Beker, Can Murat ^a   Yavuz, Izzet ^a   Ortatatli, Mesut ^a   Ozguven, Volka ^a   Pahsa, Alaaddin ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; INTERFERON; PREDNISONE; RIBAVIRIN; STEROID; VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; HEPATITIS C; HUMAN; IMMUNOTHERAPY; KIDNEY BIOPSY; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; STEROID THERAPY; TREATMENT OUTCOME; VIRUS HEPATITIS;

ADULT; ANTIVIRAL AGENTS; CRYOGLOBULINEMIA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE I, RECOMBINANT; MALE; NEPHROSIS, LIPOID;

HEPATITIS C VIRUS;

EID: 0037227998     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/10799900360520450     Document Type: Article

References (16)

1. GERBER, M.A. (1995). Pathobiologic effects of hepatitis C. J. Hepatol. 22 (Suppl. 1), 83-86.
2. McMURRAY, R.W., and ELBOURNE, K. (1997). Hepatitis C virus infection and autoimmunity. Semin. Arthritis Rheum. 26, 689-701.
3. BAILLY, F., MATTEI, A., SIAHMED, N., and TREPO, C. (1997). Uncommon side effects of interferon. J. Viral Hepatitis 4 (Suppl. 1), 89-94.
4. DOLAR, M.E. (1998). Kronik hepatit C virüs infeksiyonunda ortaya çikan renal ve immünolojik anormallikler. Viral Hepatit. Dergisi, 4, 9-11.
5. ROSTOKER, G., PAWLOTSKY, J.M., BASTIE, A., WEIL, B., and DHUMEAUX, D. (1996). Type I membranoproliferative glomerulonephritis and HCV infection. Nephrol. Dial. Transplant. 4(Suppl 11), 22-24.
6. OKADA, K., TAKISHITA, Y., SHIMOMURA, H., TSUJI, T., MIYAMURA, T., KUHARA, T., YASUTOMO, K., KAGAMI, S., and KURODO, Y. (1996). Detection of hepatitis C virus core protein in the glomeruli of patients with membranous glomerulonephritis. Clin. Nephrol. 45, 71-76.
7. LEDERER, E., and TRUONG, L. (1992). Unusual glomerular lesion in a patient receiving long-term interferon alpha. Am. J. Kidney Dis. 20, 516-518.
8. ENDO, M., OHI, H., FUJITA, T., OHSAWA, I., KANMATSUSE, K., and YAMAGUCHI, Y. (1998). Appearance of nephrotic syndrome following interferon-alpha therapy in a patient with hepatitis B virus and hepatitis C virus coinfection. Am. J. Nephrol. 18, 439-443.
9. DHIB, M., BAKHACHE, E., POSTEC, E., VANRENTERGHEM, B., LE, ROY, F., AZAR, R., FRANCOIS, A., BOLDRON, A., AMARIA, R., OZENNE, G., and HERMELIN, A. (1996). Nephrotic syndrome complicating treatment with interferon alpha. Presse Med. 25, 1066-1068.
10. CORONEOS, E., PETRUSEVSKA, G., VARGHESE, F., and TRUONG, L.D. (1996). Focal segmental glomerulosclerosis with acute renal failure associated with alpha interferon therapy. Am. J. Kidney Dis. 28, 888-892.
11. EZAKI, Y., TANAKA, U., MINOSHIMA, S., ENDOU, M., KUWAKI, K., ARIMURA, Y., NAKABAYASHI, K., and NAGASAWA, T. (1999). Focal segmental glomerulosclerosis associated with type C virus hepatitis and decrement of proteinuria by interferon alpha therapy. Nippon Jinzo Gakkai Shi 41, 83-88.
12. WILLSON, R.A. (2002). Nephrotoxicity of interferon alpha-ribavirin therapy for chronic hepatitis C. J. Clin. Gastroenterol. 35, 89-92.
13. TRAYNOR, A., KUZEL, T., SAMUELSON, E., and KANMAR, Y. (1994). Minimal change glomerulopathy and glomerular visceral epithelial hyperplasia associated with alpha-interferon therapy for cutaneous T-cell lymphoma. Nephron 67, 94-100.
14. SUNGUR, C., OZYILKAN, E., AKPOLAT, T., YASAVUL, U., TURGAN, C., and CALGAR, S. (1993). Relapse of minimal change disease associated with alpha-interferon therapy. Nephron 65, 648.
15. LOPES, L.M., LOPES, E.P., SILVA, A.E., ABREU, P.F., KIRSZTAJN, G.M., PEREIRA, A.B., and FERRAZ, M.L. (1999). Glomerulonephritis associated with hepatitis C virus infection. Rev. Soc. Bras. Med. Trop. 32, 1-6.
16. KOMATSUDA, A., IMAI, H., WAKUI, H., HAMAI, K., OHTANI, H., KODAMA, T., OYAMA, Y., MIURA, A.B., and NAKAMOTO, Y. (1996). Clinicopathological analysis and therapy in hepatitis C virus associated nephropathy. Intern. Med. 35, 529-533.